Nurix Therapeutics, Inc.

Machine Learning Engineer

Nurix Therapeutics, Inc.
Apply
4 months ago
Bengaluru, IndiaMid Level

Responsibilities

  • Design, train, and optimize custom ASR/TTS models for multilingual Indian contexts.
  • Build conversational voice agents that handle interruptions, natural pauses, and voice variability.
  • Develop voice-to-voice systems using state space models.
  • Build agentic RAG pipelines and LLM orchestration for context-aware voice agents.
  • Develop self-learning agents that improve through human workflows and feedback.
  • Collaborate with MLOps to deploy models in real-time, low-latency production environments.
  • Ensure deployed ML systems are scalable, secure, and reliable.
  • Partner with product and engineering teams to deliver production-ready features.
  • Apply advances in ASR, TTS, NLP, LLMs, and real-time inference frameworks to the product roadmap.

Requirements

  • Bachelor’s degree in Computer Science, AI/ML, or a related field.
  • 4+ years of hands-on ML engineering experience focused on speech or NLP systems.
  • Strong expertise in ASR, TTS, NLP, LLM fine-tuning, or dialogue systems.
  • Proficiency in Python and ML frameworks including PyTorch, TensorFlow, and JAX.
  • Experience designing low-latency, real-time ML applications.
  • Strong understanding of ML lifecycle, evaluation, and deployment practices.
  • Prior work on multilingual or Indian-context ASR/TTS systems.
  • Contributions to open-source ML projects or research publications.

Benefits

  • Work on cutting-edge AI and enterprise technology at a high-growth startup.
  • Have direct impact on products used by large-scale enterprise clients.
  • Work in a dynamic environment supporting professional growth and innovation.
  • Competitive compensation and performance-based incentives.
  • Bangalore, onsite work arrangement.

Tech Stack

PythonPyTorchTensorFlow

Categories

Nurix Therapeutics, Inc.

About Nurix Therapeutics, Inc.

201-500 employees

Nurix Therapeutics develops small-molecule medicines that harness the ubiquitin–proteasome system to degrade disease-causing proteins, targeting cancers and immune disorders. The company advances an internal clinical pipeline and partnered programs, generating revenue through collaborations alongside eventual drug commercialization. Founded in 2012 and headquartered in Brisbane, California, Nurix is a publicly traded company on NASDAQ.

Contact me